Engineered Protein Inhibitors of SARS-CoV-2 Entry: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 41: | Line 41: | ||
Figure 4 shows the sequence comparison between the interacting helix of ACE2 and the helices of the three minibinders. [[Image:Comparison.jpeg|400 px|left|thumb|Figure 4: The sequence differences between ACE2, AHB2, LCB1 and LCB3.]] | Figure 4 shows the sequence comparison between the interacting helix of ACE2 and the helices of the three minibinders. [[Image:Comparison.jpeg|400 px|left|thumb|Figure 4: The sequence differences between ACE2, AHB2, LCB1 and LCB3.]] | ||
==Conclusion== | ==Conclusion== | ||
[[Image:KdValues.jpg|400 px| | [[Image:KdValues.jpg|400 px|right|thumb|Figure 5: The binding affinity values (Kd) and the half maximum inhibitory concentration values (IC50) are shown for ACE2, AHB2, LCB1 and LCB3<ref name="Cao">DOI:10.1126/science.abd9909</ref>.]] | ||
